Davita Inc vs Mercadolibre Inc — how do they compare? Davita Inc trades at $179.02 (market cap $11.38B), while Mercadolibre Inc trades at $1,930 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 8.6× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, Mercadolibre Inc nearer its low. Which is the better fit depends on your goals.
| DVA | MELI | |
|---|---|---|
Market Cap | $11.38B | $98.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $2.51K |
52-Week Low | $103.87 | $1.55K |
Enterprise Value | $24.10B | $106.00B |
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →